In pursuit of α4β2 nicotinic receptor partial agonists for smoking cessation: Carbon analogs of (−)-cytisine
- 15 June 2005
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 15 (12), 2974-2979
- https://doi.org/10.1016/j.bmcl.2005.04.036
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- A sensitization–homeostasis model of nicotine craving, withdrawal, and tolerance: Integrating the clinical and basic science literatureNicotine & Tobacco Research, 2005
- Mortality in relation to smoking: 50 years' observations on male British doctorsBMJ, 2004
- A short synthesis of (±)-cytisineOrganic & Biomolecular Chemistry, 2004
- SSR591813, a Novel Selective and Partial α4β2 Nicotinic Receptor Agonist with Potential as an Aid to Smoking CessationThe Journal of pharmacology and experimental therapeutics, 2003
- Cytisine derivatives as ligands for neuronal nicotine receptors and with various pharmacological activitiesIl Farmaco, 2003
- Desensitization of neuronal nicotinic receptorsJournal of Neurobiology, 2002
- The Epidemiology of SmokingDrugs, 2002
- Characterization of the recombinant human neuronal nicotinic acetylcholine receptors α3β2 and α4β2 stably expressed in HEK293 cellsNeuropharmacology, 2000
- Rational Design of Receptor Partial Agonists and Possible Mechanisms of Receptor Partial Activation: A TheoryJournal of Theoretical Biology, 1996
- Synthesis of homobenzomorphans and the related compounds. III. 3-Methyl-2,3,4,5,6,7-hexahydro-1,6-methano-1H-3-benzazonine.CHEMICAL & PHARMACEUTICAL BULLETIN, 1976